BNC Korea Co., Ltd.

KOSDAQ:A256840 Stock Report

Market Cap: ₩376.7b

BNC Korea Past Earnings Performance

Past criteria checks 3/6

There is insufficient data on BNC Korea's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate26.6%
Return on equity9.8%
Net Margin25.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

BNC Korea's (KOSDAQ:256840) Performance Raises Some Questions

Apr 01
BNC Korea's (KOSDAQ:256840) Performance Raises Some Questions

Here's Why BNC Korea (KOSDAQ:256840) Has A Meaningful Debt Burden

Jan 25
Here's Why BNC Korea (KOSDAQ:256840) Has A Meaningful Debt Burden

Revenue & Expenses Breakdown

How BNC Korea makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A256840 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2483,77821,33320,4791,597
31 Mar 2481,57129,12821,0211,597
31 Dec 2380,99725,68620,2304,969
30 Sep 2375,2142,11623,8724,956
30 Jun 2366,175-8,45723,7774,956
31 Mar 2352,725-30,56518,6547,761
31 Dec 2242,303-44,70519,4685,396
30 Sep 2231,705-16,77716,2775,629
31 Dec 2125,249-176,26712,8218,876

Quality Earnings: A256840 has high quality earnings.

Growing Profit Margin: A256840 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A256840 has become profitable over the past 5 years.

Accelerating Growth: A256840 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A256840 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (6.1%).


Return on Equity

High ROE: A256840's Return on Equity (9.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies